106 related articles for article (PubMed ID: 8833036)
1. A fusion protein of IL-8 and a Fab antibody fragments binds to IL-8 receptors and induces neutrophil activation.
Holzer W; Petersen F; Strittmatter W; Matzku S; von Hoegen I
Cytokine; 1996 Mar; 8(3):214-21. PubMed ID: 8833036
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
[TBL] [Abstract][Full Text] [Related]
3. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.
Hammond ME; Lapointe GR; Feucht PH; Hilt S; Gallegos CA; Gordon CA; Giedlin MA; Mullenbach G; Tekamp-Olson P
J Immunol; 1995 Aug; 155(3):1428-33. PubMed ID: 7636208
[TBL] [Abstract][Full Text] [Related]
4. An anti-interleukin 8 monoclonal antibody that interferes with the binding of interleukin 8 to cellular receptors and the activation of human blood neutrophils.
Kurdowska A; Miller EJ; Cohen AB
Hybridoma; 1995 Jun; 14(3):225-33. PubMed ID: 7590784
[TBL] [Abstract][Full Text] [Related]
5. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling.
Zhong W; Zen Q; Tebo J; Schlottmann K; Coggeshall M; Mortensen RF
J Immunol; 1998 Sep; 161(5):2533-40. PubMed ID: 9725253
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
7. Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2.
Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
J Biol Chem; 1997 Jun; 272(26):16166-9. PubMed ID: 9195914
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor.
Green SP; Chuntharapai A; Curnutte JT
J Biol Chem; 1996 Oct; 271(41):25400-5. PubMed ID: 8810307
[TBL] [Abstract][Full Text] [Related]
9. G-protein coupled receptor-mediated activation of PI 3-kinase in neutrophils.
Thelen M; Didichenko SA
Ann N Y Acad Sci; 1997 Dec; 832():368-82. PubMed ID: 9704065
[TBL] [Abstract][Full Text] [Related]
10. A molecular switch of chemokine receptor selectivity. Chemical modification of the interleukin-8 Leu25 --> Cys mutant.
Lusti-Narasimhan M; Chollet A; Power CA; Allet B; Proudfoot AE; Wells TN
J Biol Chem; 1996 Feb; 271(6):3148-53. PubMed ID: 8621714
[TBL] [Abstract][Full Text] [Related]
11. Unidirectional heterologous receptor desensitization between both the fMLP and C5a receptor and the IL-8 receptor.
Blackwood RA; Hartiala KT; Kwoh EE; Transue AT; Brower RC
J Leukoc Biol; 1996 Jul; 60(1):88-93. PubMed ID: 8699129
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements of platelet chemokines for neutrophil activation.
Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
[TBL] [Abstract][Full Text] [Related]
13. Hamycin inhibits IL-8-induced biologic response by modulating its receptor in human polymorphonuclear neutrophils.
Manna SK; Samanta S; Samanta AK
J Immunol; 1997 Nov; 159(10):5042-52. PubMed ID: 9366432
[TBL] [Abstract][Full Text] [Related]
14. CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils.
Hauser CJ; Fekete Z; Goodman ER; Kleinstein E; Livingston DH; Deitch EA
Shock; 1999 Dec; 12(6):428-37. PubMed ID: 10588510
[TBL] [Abstract][Full Text] [Related]
15. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
[TBL] [Abstract][Full Text] [Related]
16. Regulation of interleukin-8 receptor expression in human polymorphonuclear neutrophils.
Manna SK; Bhattacharya C; Gupta SK; Samanta AK
Mol Immunol; 1995 Aug; 32(12):883-93. PubMed ID: 7565815
[TBL] [Abstract][Full Text] [Related]
17. Transendothelial migration of neutrophils involves integrin-associated protein (CD47).
Cooper D; Lindberg FP; Gamble JR; Brown EJ; Vadas MA
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3978-82. PubMed ID: 7732016
[TBL] [Abstract][Full Text] [Related]
18. Dansyl cadaverine regulates ligand induced endocytosis of interleukin-8 receptor in human polymorphonuclear neutrophils.
Ray E; Samanta AK
FEBS Lett; 1996 Jan; 378(3):235-9. PubMed ID: 8557108
[TBL] [Abstract][Full Text] [Related]
19. A novel leukocyte chemotactic and activating cytokine, interleukin-8 (IL-8).
Mukaida N; Harada A; Matsushima K
Cancer Treat Res; 1995; 80():261-86. PubMed ID: 8821581
[No Abstract] [Full Text] [Related]
20. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
